Past publications have highlighted the influence of postdialysis plasma pH on the measured fraction unbound in plasma (fup). There is disparity in the industry as to which of two main methods is more suitable for controlling postdialysis plasma pH: the use of either a stronger buffer or a CO 2 atmosphere for the incubation. In the current study, it has been found that 10% CO 2 could be too high for the buffering capacities of both 100 mM sodium phosphate (pH 7.40 decreased to pH 6.90 after a 6-h incubation) and plasma (decreased below pH 7.40 after a 6-h incubation). To provide appropriate control over the postdialysis plasma pH, for a range of species, it is proposed that a standard phosphate buffer strength (100 mM) and pH (7.40) in combination with a 5% CO 2 atmosphere be used for equilibrium dialysis. Furthermore, statistically significant differences in fup values obtained with a pH difference of less than 0.32 pH unit have been demonstrated. An acceptance range for postdialysis plasma pH in routine in vitro fup screening assays of pH 7.40 ؎ 0.10 is recommended.
Introduction
Determining the extent of drug binding to plasma proteins is an essential step in the drug discovery process for assessing drug disposition (Lombardo et al., 2002; Musteata et al., 2006; Trainer, 2007; van Steeg et al., 2009 ). Quantification of a drug's plasma protein binding [and hence fraction unbound in plasma (fup)] is essential for extrapolation of preclinical efficacy data, prediction of in vivo clearance from in vitro data, and estimation of free drug concentration in tissues (Kalvass and Maurer, 2002; Summerfield et al., 2008; He et al., 2009 ). Interspecies differences in plasma protein binding (PPB) need to be considered for prediction of volume of distribution and clearance in humans (Benet and Hoener, 2002) .
Equilibrium dialysis is a well recognized and preferred method for determining the binding of drugs to plasma proteins (Chuang et al., 2009; Howard et al., 2010) . Older equilibrium dialysis equipment, for example, systems from Dianorm (Munich, Germany), can be laborintensive and time-consuming to use and difficult to automate. Several 96-well format equilibrium dialysis devices have been developed and validated, thus facilitating assay automation (Kariv et al., 2001; Banker et al., 2003; Wong et al., 2009 ; http://www.HTDialysis.com; http://www.harvardappartus.com). However, these methods still require soaking of membranes and washing and assembly of equipment, thereby increasing the probability of leakage and contamination. With the 96-well plate for RED (Thermo Fisher Scientific, Loughborough, UK), there are no washing or assembly steps. Several groups are using this plate (Waters et al., 2008 ; see http://www.piercenet.com for poster presentations).
It has been observed that buffer choice in equilibrium dialysis assays affects fup (Guentert and Oie, 1982) . It was subsequently reported that there is a difference in pH between fresh plasma and stored plasma (Fura et al., 2003) . This was attributed to rapid CO 2 loss during plasma collection, storage, and incubation, causing an increase in pH. The equilibria of CO 2 in water (eqs. 1a and 1b) are widely known (Roughton and Booth, 1938) and are nonionic and slow, with an equilibration time of several minutes. The reaction time is catalyzed to milliseconds by carbonic anhydrase, which is not present in plasma (Kitching and Edge, 2002 
It has been shown that an increase in plasma pH can have a significant influence on the extent of drug binding to plasma proteins (Paxton and Calder, 1983; Kremer et al., 1988; Hinderling and Hartmann, 2005; Wan and Rehngren, 2006; Kochansky et al., 2008) . In attempts to address this issue, Wan and Rehngren (2006) determined that stronger buffers were required to minimize pH shifts, whereas others advocated the use of a 10% CO 2 atmosphere (Fura et al., 2003; Musteata et al., 2006; Kochansky et al., 2008) or initial purging of plasma with CO 2 followed by ultracentrifugation for determination of fup (Nilsson and Schmidt, 2001) . There is further discussion in the literature, supporting the use of either stronger buffer or incubation in a CO 2 atmosphere (Banker and Clark, 2008) . Past studies have also examined the effect of a relatively wide postdialysis plasma pH range (of between pH 6 and 9) on fup (Hinderling and Hartmann, 2005; Wan and Rehngren, 2006) . In a normal physiological state the in vivo arterial blood pH range is much narrower, within pH 7. 35 and 7.45 (Eckert et al., 1997; Porter and Kaplan, 2006; Troy, 2006; Waugh and Grant, 2007) . This is due to the homeostatic control of blood hydrogen ion concentration by complex acid-base balance mechanisms. The range of postdialysis plasma pH values between pH 6 and 9 is only observed in abnormal circumstances (e.g., hypoxia and hyperventilation) or in disease states such as metabolic acidosis or alkalosis (Davenport, 1974) .
In the current study, 22 marketed drugs were chosen for a series of investigations using the disposable 96-well RED plate and ultrapressure liquid chromatography (UPLC)-tandem mass spectrometry for the determination of fup. These compounds had a broad range of physicochemical properties and protein binding. Although the use of either a stronger buffer or incubation in a CO 2 atmosphere resulted in improved pH control (Banker and Clark, 2008) , we demonstrate that it is necessary to use both of these factors in combination. Moreover, there are other factors such as predialysis buffer pH that influence accurate control of postdialysis plasma pH. These factors have been taken into consideration and applied to a range of species. It is proposed that the postdialysis plasma pH is the most important measurement to obtain rather than a during-dialysis plasma pH (or pH shift from start to finish) because it has been postulated that pHdependent changes in plasma protein binding are reversible (Kochansky et al., 2008) . Furthermore, data are presented to highlight the fact that the method of postdialysis pH measurement is critically important. The impact of a postdialysis plasma pH variation of less than 0.50 pH unit on the obtained value of fup is discussed.
Materials and Methods
Materials. Pooled human plasma (EDTA as coagulant) was obtained fresh from in-house donors (n ϭ 3) or from BioChemed Services (Winchester, VA) and stored at Ϫ20°C. Plasma from all other species (cynomolgus monkey, Wistar rat, Sprague-Dawley rat, ICR mouse, C57 mouse, and beagle dog) was supplied by Harlan Seralab (Haywards Heath, UK) and stored at Ϫ20°C. Test compounds (buspirone, carbamazepine, cinoxacin, clozapine, diazepam, diclofenac, diltiazem, fluoxetine, haloperidol, imipramine, midazolam, milnacipran, mirtazapine, nicardipine, paroxetine, propranolol, quinidine, risperidone, tranylcypromine, trimipramine, verapamil, and warfarin) were obtained from Sigma-Aldrich (Dorset, UK) with measured pK a values being taken from the literature. The RED plates, 96-well plates for analysis, gas-permeable lid seals, Eppendorf tubes, and lids were purchased from Thermo Fisher Scientific. Deionized water was obtained from a purification system (Milli-Q Academic with a Quantum Ex Ultrapure Organex cartridge; Millipore Corporation, Watford, UK). High-performance liquid chromatography-grade acetonitrile, formic acid, ammonium formate (aqueous), methanol, isopropanol, and DMSO were purchased from Thermo Fisher Scientific. The pH of the buffers, which were supplied in sachets, was determined in-house (predialysis pH) because the range stipulated by manufacturers was too wide (e.g., pH 7.4 Ϯ 0.2).
Buffers. The following four buffers were used in this study: buffer 1, 10 mM phosphate-buffered saline, 140 mM NaCl, and 2.7 mM KCl (predialysis pH 7.43; Sigma-Aldrich); buffer 2, 100 mM sodium phosphate and 150 mM NaCl (predialysis pH 7.00; Thermo Fisher Scientific); buffer 3, 100 mM sodium phosphate and 150 mM NaCl [made in-house to pH 7.40 (unless otherwise stated) as detailed below]; and buffer 4, 8.3 mM phosphate-buffered saline, 140 mM NaCl, and 2.7 mM KCl [made in-house to pH 7.40 as detailed below (used by Kochansky et al., 2008) ].
Buffer 3 was prepared by the following method. A basic solution was made by dissolving 14.2 g/l Na 2 HPO 4 and 8.77 g/l NaCl in deionized water. An acidic solution was made by dissolving 15.6 g/l NaH 2 PO 4 ⅐ 2H 2 O and 8.77 g/l NaCl in deionized water. The basic solution was then titrated with the acidic solution to pH 7.40 (or as required).
Buffer 4 was prepared as per buffer 3 with adjusted constituents and concentrations: basic solution, 0.2 g/l Na 2 HPO 4 , 0.2 g/l KCl, and 8 g/l NaCl; and acidic solution, 1.15 g/l KH 2 PO 4 , 0.2 g/l KCl, and 8 g/l of NaCl.
Dialysis
Method. An initial in-house validation that showed no fup difference between singly incubated and coincubated (cassetted) compounds (data not shown) was completed. Results were consistent with the findings of Wan and Rehngren (2006) . Measurement of fup was performed using a disposable 96-well RED plate with cassettes of five compounds (pooling of compounds predialysis), each run in triplicate. The RED plate and all buffer and plasma solutions were heated to 37°C before dialysis. All compounds were freshly prepared from powder at a stock concentration of 10 mM in DMSO. Cassettes were prepared by mixing 10 l of each 10 mM test compound stock (five test compounds per cassette) and 50 l of DMSO to yield a cassetted compound concentration of 1 mM. Subsequently, 10 l of the cassette was spiked into 990 l of plasma and thoroughly mixed, resulting in a final compound concentration of 10 M for dialysis. The spiked plasma (300 l) was added to the donor side of the RED plate. Buffer (500 l) was added to the receiving well. The RED plate was sealed with a gas-permeable lid, and dialysis was performed at a shaking speed of 800 rpm (Eppendorf Thermomixer Comfort; Thermo Fisher Scientific) within a 5% CO 2 incubator for 6 h at 37°C. Previous in-house validation showed that equilibrium was achieved within a 6-h incubation time. After dialysis, 20 l of sample from the plasma chamber of the RED plate was added to 80 l of fresh buffer in a clean 96-well analytical plate, and 80 l of sample was removed from the buffer chamber and added to 20 l of fresh blank plasma. These samples were immediately quenched with 300 l of acetonitrile containing internal standard (positive ion mode: desipramine at 0.5 g/ml; negative ion mode: tolbutamide at 0.25 g/ml). The plate was shaken for 10 min using a Siemens MicroMix 5 (EURO/DPC Ltd., Gwynedd, UK) set at amplitude 9, form 20. The plate of quenched samples was stored for 15 min at Ϫ80°C to facilitate protein precipitation and subsequently centrifuged at 3000g at 4°C for 10 min. After centrifugation, a portion of the resulting supernatant (100 l) was transferred to a clean 96-well analytical plate, and 100 l of deionized water was added.
Several experimental studies were performed in three stages. The first stage (1 and 2 below) was to investigate the impact of sealing or not sealing the RED plate within a CO 2 incubator. In addition, the influence of CO 2 incubation on buffer and plasma solutions with and without dialysis was studied. The next stage (3 and 4 below) was to implement observations from stage 1 and to investigate further the selection of standard buffer/atmospheric conditions conducive to reaching a postdialysis plasma of pH 7.40 for a range of species. The third and final stage (5 below) was to compare the fup values obtained using proposed standard buffer/atmospheric conditions (from results generated in stages 1 and 2) to another three widely used buffer/atmospheric conditions (the difference in fup values is attributed to postdialysis plasma pH differences).
1. Influence of incubation in a CO 2 atmosphere on volume loss from the system and pH of buffer and plasma. Because of the unavailability of a commercially supplied buffer of strength similar to that of buffer 2 but starting at pH 7.40, it was made in-house (buffer 3, see above). An experiment was conducted without dialysis in which 500 l of buffers 1, 2, 3, or 4 or 300 l of either human or Wistar rat plasma only were placed in Eppendorf tubes. These tubes were then incubated under normal atmospheric conditions (nonshaking water bath) or in a 5 or 10% CO 2 atmosphere (thermoshaker), all at 37°C. The pH of the separate buffers or plasmas was measured in situ after 6 h. Further pH measurements were made for buffer 3, human plasma, and Wistar rat plasma every 5 min for 30 min after removal from the CO 2 incubator. To measure volume loss over the 6-h dialysis period used in this study, the RED plate was weighed (a) empty, (b) after the addition of assay components, and (c) after the 6-h incubation period. The percent volume lost was calculated according to eq. 2:
This calculation was used to compare the volume loss under different conditions: with no lid in the 5% CO 2 incubator, with a gas-permeable lid in the 5% CO 2 incubator, and with an adhesive foil lid under normal atmospheric conditions (within a closed lid thermoshaker). 2. Postdialysis plasma pH: influence of CO 2 and method for pH determination. Human plasma from different batches was dialysed against either buffer 3 or 4 and incubated at either 5% or 10% CO 2 . pH readings were made at 37°C using two methods for comparison: pH measurement 552 CURRAN ET AL.
at ASPET Journals on August 14, 2017 dmd.aspetjournals.org method 1: pH was measured in situ, in triplicate, immediately after a 6-h dialysis and averaged; and pH measurement method 2: plasma from triplicate wells was aspirated by pipette and pooled into a clean 96-well analytical plate, resulting in the pH measurement being taken after approximately 20 min after a 6-h dialysis. 3. Applicability of standard conditions to plasma from seven species.
Plasma from seven species was separately dialysed using four buffer/ atmospheric combinations. All pH readings were made in triplicate (see pH method 1 above) at 37°C after a 6-h dialysis. The assay was repeated on 3 separate days. 4. Influence of buffer predialysis pH on postdialysis plasma pH. Buffer 3 was prepared with various predialysis pH values and dialysed against human plasma in a 5% CO 2 environment for 6 h with a cassette of five drugs (warfarin, carbamazepine, propranolol, nicardipine, and diazepam) to mimic normal assay conditions. All pH readings were made in duplicate (see pH method 1 above) at 37°C after a 6-h dialysis. 5. Influence of postdialysis plasma pH on fup. Assays were performed as per dialysis method (see above), with alteration of buffer/atmospheric conditions. Paired t tests were performed using Minitab software (Minitab Ltd., Coventry, UK) for each buffer/atmospheric condition and each compound. All pH readings were made in triplicate (see pH method 1 above) at 37°C after a 6-h dialysis. Instrumentation and Analytical Method. The Eppendorf Thermomixer Comfort was set to 42°C. Initial tests were performed in situ to confirm that this temperature was required to achieve and maintain the liquids in the RED plate at 37°C. pH measurements were recorded using a Beckman pH meter equipped with a Hamilton Minitrode pH electrode, which was calibrated before every experiment using commercially available standard buffers of known pH (phthalate, pH 4; phosphate, pH 7; and borate, pH 10; Thermo Fisher Scientific). A nonhumidified incubator with a variable CO 2 concentration setting was used at 37°C (LEEC, Nottingham, UK).
All analyses were performed on a Waters Acquity ultra-pressure liquid chromatograph coupled to a Quattro Premier XE mass spectrometer with electrospray ionization (Waters, Manchester, UK) . The acquisition and UPLC run time was 0.9 min. The aqueous mobile phase (A) was 10 mM ammonium formate adjusted to pH 3.5 with formic acid, and the organic mobile phase (B) was acetonitrile. The flow rate was 0.8 ml/min through an Acquity UPLC BEH C18 column (2.1 ϫ 50 mm, 1.7-m particle size; Waters) maintained at 45°C. The proportion of mobile phase B was initially 5% and increased linearly (curve 6) to 100% over 0.4 min where it was held for 0.3 min and then was instantly decreased (curve 1) back to 5% and finally held at this for the remaining 0.2 min to reequilibrate the column. The injection volume was 3 l (positive ionization mode) with the autosampler operating in partial loop with needle overfill mode. As an alternative, 10 to 20 l (negative ionization mode or for compounds with poor sensitivity) was used in full loop mode. Between injections the autosampler needle was washed with 0.8 ml of a strong wash mixture comprising equal proportions of water, acetonitrile, methanol, and isopropanol with 0.1% formic acid. The source temperature of the mass spectrometer was maintained at 150°C with a desolvation temperature of 450°C. The most abundant product ion of each pseudomolecular ion,
Ϫ was chosen in multiple reaction monitoring mode with cone voltage and collision energy optimized for detection sensitivity. Quantitation of compounds was achieved first by obtaining the instrument response (analyte/internal standard peak area) and second by creation of a 9-point calibration line. The calibration standards were representative of the final concentrations expected in the samples and were spiked into buffer-plasma (80:20, v/v) to matrix match with the final sample composition. Regression models were fitted using linear regression with 1/x weighting. If this model produced a biased percent error residuals plot, then quadratic regression with 1/x weighting was used. Percent PPB and fup were calculated according to eqs. 3 and 4, respectively.
where C b and C p represent the calculated concentration of the compound from the buffer and plasma chambers, respectively, and D b and D p represent the final dilution of the buffer and plasma samples upon normalization (which accounts for sample matrix matching).
fup ϭ (100 Ϫ % PPB) 100
Recovery was measured to ensure robustness of repeat measurements. This was calculated as in eq. 5.
Results
Influence of Incubation in a CO 2 Atmosphere on Volume Loss from the System and pH of Buffer and Plasma. The effect of incubation in a CO 2 atmosphere on the pH of separate buffers and plasmas (i.e., with no dialysis) is shown in Table 1 . pH measurement was made in situ immediately after 6 h of incubation at 37°C. Plasma with no cap showed an increase in pH under normal atmospheric conditions and tended toward pH 7.40 under a 5% CO 2 atmosphere. Buffers with no cap exhibited a decrease in pH under a CO 2 atmosphere with the stronger buffers (2 and 3) giving the smallest decrease. A 10% CO 2 atmosphere produced a larger decrease in pH than 5% CO 2 for all buffers. Postincubation plasma increased in pH upon removal from the CO 2 incubator after a 6-h incubation, as did buffer 3 (Fig. 1) .
A 6-h dialysis with the RED plate in 5% CO 2 at 37°C with no lid and with a gas-permeable lid resulted in volume losses of 16.6 and 6.6%, respectively. Under normal atmospheric conditions in a thermoshaker, the volume loss was minimal (0.1%).
Postdialysis Plasma pH: Influence of CO 2 and Method for pH Determination. After observation of the effect on pH of incubation in a CO 2 atmosphere on separate buffers and plasmas (1 above), dialysis experiments were undertaken to compare the effect of two different CO 2 incubation concentrations on postdialysis plasma pH. Buffers 3 and 4 (different strengths but both starting at pH 7.40) were incubated at either 5 or 10% CO 2 . This process was repeated on different days to assess reproducibility. For buffer 3, this incubation was also performed using five (warfarin, carbamazepine, propranolol, nicardipine, and diazepam), one (warfarin), or no compounds to assess any compound or cassetting influence on the postdialysis plasma pH. Incubation in a 10% CO 2 atmosphere resulted in postdialysis plasma pH values less than pH 7.40 for both buffers (Table 2) . Buffer 3 under a 5% CO 2 atmosphere produced postdialysis plasma pH values close to pH 7.40. The postdialysis plasma pH measurement method 2 (aspirating and pooling) resulted in pH values 0.2 to 0.3 unit higher than method 1 (in situ). On the basis of these observations from stage 1 (1 and 2 above), 5% CO 2 and buffer 3 (100 mM at pH 7.40) are suggested as optimal and hereafter referred to as the standard conditions. Applicability of Standard Conditions to Plasma from Seven Species. A comparison of postdialysis plasma pH values for seven different species was made. The plasmas were dialysed against buffers 2 and 3 (both having same strength but differing in predialysis pH) either in a 5% CO 2 atmosphere or under normal atmospheric conditions. Nine separate measurements were made (n ϭ 3 on 3 separate days) and the data are shown in Fig. 2 . The standard conditions (c) consistently reached close to pH 7.40 for all seven species. Use of the same buffer (buffer 3) with a lower predialysis pH and/or under normal atmospheric conditions did not achieve a postdialysis pH of 7.40.
Influence of Buffer Predialysis pH on Postdialysis Plasma pH.
To assess the robustness of the standard conditions (1-3 above), buffer 3 was subsequently prepared at eight different predialysis pH values, and the respective postdialysis human plasma pH values were obtained (Fig. 3) . The predialysis plasma pH was 7.61. Buffer with a predialysis pH of 7.40 produced postdialysis plasma of the same pH (7.40), whereas all other predialysis buffer pH values produced disparate postdialysis plasma pH values, which tended toward pH 7.40.
Influence of Postdialysis Plasma pH on fup. To obtain a comparison of fup values at differing postdialysis plasma pH values, a set of 22 drugs were dialysed in human plasma against four buffer/ atmospheric combinations (Table 3) . A control was included in every cassette with mean fup values and S.D. taken across the assay to monitor repeatability: warfarin (fup CV was 21%) and carbamazepine (fup CV was 14%). Compound recovery was Ͼ70% with the exception of midazolam (63%). The buffer/atmospheric combinations and resulting postdialysis plasma pH values were as follows: buffer 1 with normal atmospheric conditions (pH 7.72); buffer 2 with normal atmospheric conditions (pH 7.22); buffer 3 with 5% CO 2 (pH 7.40) (standard conditions); and buffer 4 with 5% CO 2 (pH 7.63).
The impact of postdialysis plasma pH on fup measurement can be assessed by calculating the fup fold difference of two buffer/ atmospheric combinations (one fup divided by the other; where no difference translates to fold difference ϭ 1). This result has been displayed for decreasing postdialysis plasma pH differences (Figs. 4,  a-c) . The statistical significance of the fup fold difference for each comparison was determined using paired t tests.
Discussion
Influence of Incubation in a CO 2 Atmosphere on Volume Loss from the System and pH of Buffer and Plasma. There are some technical difficulties associated with performing equilibrium dialysis in a CO 2 atmosphere. It is necessary to have the incubations uncapped (to allow access of CO 2 ); however, the use of a gas-permeable lid with the RED plate resulted in greater volume loss during incubation than with a foil seal lid. Whereas increasing levels of CO 2 can result in increased formation of carbamino groups on plasma proteins (Eckert et al., 1997) , the effect on PPB is unknown.
Consistent with previously published findings (Fura et al., 2003; Kochansky et al., 2008) , incubation in a CO 2 atmosphere prevented the increase in plasma pH observed under normal atmospheric con-FIG. 1. pH time course of human plasma, Wistar rat plasma, and buffer 3 upon removal into normal atmospheric conditions after a 6-h incubation under a 5% CO 2 atmosphere. (Table 1) . Upon incubation in a 5% CO 2 atmosphere, plasma with a predialysis pH either greater than or less than 7.40 tended toward pH 7.40, whereas a predialysis plasma pH close to 7.40 remained stable. This has also been observed by other groups (Fura et al., 2003; Musteata et al., 2006; Kochansky et al., 2008) and could be due to the ability of plasma proteins to act as a weak buffer, as they are known to do in vivo (Troy, 2006) . All buffers exhibited a decrease in pH upon incubation in a 5 or 10% CO 2 atmosphere. The observed decrease in buffer pH could be due to a shift in the buffering equilibrium of phosphate buffer (monoprotic to diprotic phosphate) caused by CO 2 absorption and/or increased formation of carbonic acid (product in eq. 1a). It has been demonstrated that in water, phosphate buffers catalyze the reaction shown in eq. 1a but not that shown in eq. 1b (Roughton and Booth, 1938) . It has also been recognized that potassium phosphate buffer is affected by CO 2 absorption to the same extent as water at 40°C (Lívanský, 1982) .
Although incubation in a CO 2 atmosphere was shown to prevent CO 2 loss from plasma, 10% CO 2 may be unsuitable because it resulted in a plasma pH decrease less than 7.40 (Table 1 ). In addition, after incubation of plasma or buffer under a CO 2 atmosphere, a subsequent return to normal atmospheric conditions resulted in a resumption of CO 2 loss with an associated increase in pH (Fig. 1) .
Postdialysis Plasma pH: Influence of CO 2 and Method for pH Determination. It is postulated that the 0.2 to 0.3 pH unit discrepancy between the two methods for measuring postdialysis plasma pH (Table 2) is due to the resumption of CO 2 loss after removal from the CO 2 incubator. It is therefore proposed that postdialysis plasma pH be measured in situ, once aliquots have been removed for analysis. If pH measurement within the CO 2 incubator is not feasible, sampling for analysis and pH measurement steps should be performed immediately after removal of the plate from the CO 2 incubator. As an alternative, after sampling, the plate could be returned to the incubator before pH measurement. Kochansky et al. (2008) reported that, using buffer 4, a 10% CO 2 environment, and pH measurement method 2 (i.e., pH measurement made approximately 20 min after removal from the incubator) the postdialysis plasma pH was pH 7.4 Ϯ 0.2. In the current study, using pH measurement method 2, postdialysis pH values of 7.53 and 7.54 were found (assays performed on separate days). However, when the pH was measured immediately in situ (method 1), pH values of 7.22 and 7.34 were found. Thus, it is possible that the pH value of 7.4 Ϯ 0.2 reported by Kochansky et al. (2008) could have arisen from a lower postdialysis plasma pH and subsequent loss of CO 2 before pH determination.
The observation that CO 2 concentration influences the postdialysis plasma pH may highlight the requirement for interlaboratory investigation of an optimal CO 2 level of approximately 5% because there are variations in seals, models, and set-up of incubators and thermoshakers, which may affect CO 2 permeation into liquids. It was found that the pooling or addition of compounds did not affect the postdialysis plasma pH ( Table 2) .
Applicability of Standard Conditions to Plasma from Seven Species. The use of atmospheric conditions and buffer 1 resulted in human plasma postdialysis pH values of 7.72. This result was in agreement with the findings of Wan and Rehngren (2006) that 10 mM buffer strength is not adequate for control of pH. These authors reported that a 134 mM sodium phosphate buffer at pH 7.0 under normal atmospheric conditions minimized pH shift (0.4 -0.5 pH unit), quoting a postdialysis plasma pH value of 7.51 with an 18-to 22-h dialysis time. The current study demonstrated that with similar buffer/atmospheric conditions [ Fig. 2b, conditions (a) ], postdialysis plasma pH values were lower than physiological pH across all seven species (between 7.17 and 7.31). The standard conditions, (c), were the only conditions studied that consistently produced postdialysis plasma pH values close to pH 7.40 (e.g., human pH 7.40 Ϯ 0.04) (Fig. 2) .
Influence of Predialysis Buffer pH on Postdialysis Plasma pH. It can be deduced from Figs. 2 and 3 that, in addition to using a stronger buffer, the predialysis buffer pH for incubation in a 5% CO 2 atmosphere must be at pH 7.40 to consistently reach the target postdialysis plasma pH of 7.35 to 7.45. This value has been found to be appropriate for the range of species and predialysis plasma pH values routinely observed. For human plasma, when the predialysis buffer pH was not pH 7.40, there was a tendency for the postdialysis plasma pH to deviate toward pH 7.40 (Fig. 3) . As discussed previously, this result could be due to the ability of plasma proteins to act as a weak buffer. It was also discovered that commercially available buffer mixes could not be prepared within the necessary tolerance (pH 7.4 Ϯ 0.2) to ensure the required reproducibility of postdialysis plasma pH.
Influence of Postdialysis Plasma pH on fup. This study confirms the findings of Wan and Rehngren (2006) that compound class and pK a play an important role in the influence of pH on fup (Fig. 4, a-c) . In general, the degree of protein binding increases with hydrophobicity (Colmenarejo et al., 2001) ; therefore, for basic drugs, an increase in pH results in an increase in the ratio of un-ionized (hydrophobic) species and therefore potentially a decrease in fup. This principle and the application of the Henderson-Hasselbalch equation (which quantifies the relative ratio of un-ionized to ionized species at pH 7.40 of a drug with a known pK a ) can be used to predict an increase or decrease in fup for a drug at a given postdialysis plasma pH compared with pH 7.40. In addition, it could be predicted that, for the pH range studied, a greater difference in fup would be observed for compounds within a pK a range of 6.4 to 8.4 (e.g., nicardipine has a pK a of 7.4; at pH 7.40, 50% will be un-ionized; at pH 7.90, 69% will be un-ionized). This observation is substantiated by the data shown in Fig. 4 , a-c, for which basic drugs in this pK a range show the most prominent shift in fup fold difference. For acids, the opposite would be expected; however, other groups have shown that some acids exhibit a decrease in fup with an increase in pH (Panjehshahin et al., 1992; Hinderling and Hartmann, 2005) . We also observed this phenomenon for warfarin, which could potentially be due to a change in ionization of albumin, a charge-charge interaction with the lysine residue on albumin, or a change in conformation of albumin (Kasai-Morita et al., 1987) . It is important to highlight the fact that this last explanation could also influence the binding of neutral drugs.
The current study has shown a statistically significant difference in fup for 16 of 22 compounds at postdialysis plasma pH 7.22 compared with pH 7.72 (pH difference of 0.50) (Fig. 4a) . This result indicates that a postdialysis plasma pH acceptance range of pH 7.40 Ϯ 0.25 is too wide. However, with a pH difference range of 0.23 (Fig. 4c) only 1 of the 22 compounds produced a statistically significant difference in fup, indicating that a range of pH 7.40 Ϯ 0.10 may be acceptable. The influence of a smaller pH range on fup values would be difficult to investigate given inherent pH electrode, experimental, and instrumental errors. Some of the compounds exhibiting statistically significant differences in fup are highly bound to plasma proteins, and these differences could therefore substantially influence interpretation of pharmacological and pharmacokinetic data.
To conclude, to improve the reproducibility of in vitro fup measurements, we propose that dialysis be performed using a minimum strength buffer of 100 mM sodium phosphate prepared at pH 7.40 and a 5% CO 2 atmosphere with in situ postdialysis plasma pH routinely measured for quality control. This protocol has been shown to provide postdialysis plasma pH consistently within the pH range of 7.35 to 7.47 for seven different species. An acceptance criterion of pH 7.40 Ϯ 0.10 is recommended for robust and physiologically relevant fup measurements. Inhouse investigations suggest that these proposals could also apply to other methods of equilibrium dialysis.
